Genmab posts Q3 2026 DARZALEX net sales of USD 4.24 billion, J&J data show

GMAB•2026-10-13

Genmab reported worldwide DARZALEX net trade sales of USD 4.24 billion in Q3 2026, based on figures reported by J&J. U.S. sales were USD 2.53 billion and rest-of-world sales were USD 1.71 billion.

1. Quarterly sales

Worldwide DARZALEX net trade sales reached USD 4.24 billion in Q3 2026, including USD 2.53 billion in the U.S. and USD 1.71 billion in the rest of the world. Genmab earns royalties on worldwide sales under its exclusive global license to J&J, covering intravenous and subcutaneous forms.

Sources

Genmab posts Q3 2026 DARZALEX net sales of USD 4.24 billion, J&J data show

Sec

Genmab posts Q3 2026 DARZALEX net sales of USD 4.24 billion, J&J data show

1. Quarterly sales

Related News

Multi Units Luxembourg corrects notice on 1-for-100 split for Amundi Core S&P 500 Swap UCITS ETF share class

Uber executive overseeing robotaxi expansion reportedly will depart

Prelude announces Lilly collaboration to evaluate PRT13722 in breast cancer

Sources

Genmab posts Q3 2026 DARZALEX net sales of USD 4.24 billion, J&J data show

BioNTech's mRNA cancer therapy misses first goal in head and neck trial

Ollie’s Bargain Outlet rises on additional $500 million stock buyback